The Institute for Precision Health is a joint venture between the University and University Hospitals of Leicester. Our vision is to enhance Leicester’s reputation as an international centre of excellence in precision health, uncovering disease mechanisms, developing novel diagnostics and therapies and translating them for patient and societal benefit.
With over £40 million of competitively won funding secured annually for health-related research and the excellence of our Clinical Medicine research acknowledged in REF2021, the Institute for Precision Health is ideally placed to facilitate world-leading clinical research across our priority areas.
The Institute for Precision Health offers numerous opportunities to take part in events including, showcasing research, industrial collaborations, development of research partnerships, networking, and public engagement. We are proud to support our PhD student cohort, and welcome suggestions for further events that help to champion early career researcher aspirations.
Leicester Drug Discovery and Diagnostics (LD3)
LD3 supports translational research across the Colleges, providing research and commercialisation expertise underpinned by pump-prime funding opportunities from sequential MRC IAA awards. This allows researchers to accelerate the development of medicines, therapies, diagnostic tests and devices that have ‘real world benefit’ for patients.